Congestive Heart Failure in Dogs: Welfare-Centred Management

Congestive heart failure is a progressive condition in dogs that requires careful medical management to control symptoms, maintain quality of life, and make compassionate end-of-life decisions.

Key Facts

Mitral valve disease causing congestive heart failure is the most common cardiac condition in dogs, particularly in small breeds
Cavalier King Charles Spaniels have the highest prevalence, with most developing mitral valve disease by middle age
Clinical signs of congestive heart failure include coughing, exercise intolerance, laboured breathing, and collapse
Medical management with furosemide, pimobendan, and ACE inhibitors controls fluid accumulation and improves cardiac function
The QUEST trial demonstrated that pimobendan in pre-clinical disease delays onset of heart failure by an average of 15 months
Acute decompensated heart failure is a medical emergency requiring immediate hospitalisation and intensive diuresis
Median survival from onset of congestive heart failure is 9-12 months with appropriate medical management

Welfare Considerations

Heart failure management in dogs involves the ongoing challenge of maintaining quality of life while managing a progressive condition that will ultimately be fatal. The welfare goals are control of dyspnoea — the breathlessness that is one of the most aversive symptoms of decompensated heart failure — maintenance of activity and social engagement, prevention of acute crises, and timely end-of-life decision-making when medical management can no longer achieve these goals. Breathlessness in dogs, as in humans, causes profound distress; dogs in acute decompensated failure that cannot breathe adequately are experiencing one of the most severe acute welfare emergencies in companion animal medicine. Appropriate diuresis restores respiratory comfort rapidly in many cases, dramatically improving short-term welfare. Ongoing management requires regular monitoring of respiratory rate — which owners can measure at home as an early indicator of decompensation — and prompt veterinary contact when rates increase. The end-of-life decision in heart failure is particularly complex because progression is gradual; quality of life assessment tools help owners and veterinarians recognise when euthanasia will prevent rather than shorten suffering.

What You Can Do

Monitor resting respiratory rate daily in dogs with known cardiac disease as an early indicator of decompensation
Seek emergency veterinary care immediately if a dog with heart disease shows laboured breathing or collapse
Discuss quality of life goals and end-of-life indicators with your veterinarian at diagnosis to plan ahead
Consider pimobendan in pre-clinical mitral valve disease if echocardiographic criteria are met to delay progression